Deciphering the Role of B Cells in Multiple Sclerosis—Towards Specific Targeting of Pathogenic Function
出版年份 2017 全文链接
标题
Deciphering the Role of B Cells in Multiple Sclerosis—Towards Specific Targeting of Pathogenic Function
作者
关键词
-
出版物
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Volume 18, Issue 10, Pages 2048
出版商
MDPI AG
发表日期
2017-09-26
DOI
10.3390/ijms18102048
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Differential effects of FTY720 on the B cell compartment in a mouse model of multiple sclerosis
- (2017) Kathrin Bail et al. Journal of Neuroinflammation
- Dimethyl fumarate induces changes in B- and T-lymphocyte function independent of the effects on absolute lymphocyte count
- (2017) Erin E Longbrake et al. Multiple Sclerosis Journal
- Ocrelizumab versus Interferon Beta-1a in Relapsing Multiple Sclerosis
- (2017) Stephen L. Hauser et al. NEW ENGLAND JOURNAL OF MEDICINE
- Ocrelizumab versus Placebo in Primary Progressive Multiple Sclerosis
- (2017) Xavier Montalban et al. NEW ENGLAND JOURNAL OF MEDICINE
- Interpreting Lymphocyte Reconstitution Data From the Pivotal Phase 3 Trials of Alemtuzumab
- (2017) David Baker et al. JAMA Neurology
- Dimethyl fumarate induces changes in B- and T-lymphocyte function independent of the effects on absolute lymphocyte count
- (2017) Erin E Longbrake et al. Multiple Sclerosis Journal
- Dimethyl fumarate alters B-cell memory and cytokine production in MS patients
- (2017) Matthew D. Smith et al. Annals of Clinical and Translational Neurology
- Myelin-reactive antibodies initiate T cell-mediated CNS autoimmune disease by opsonization of endogenous antigen
- (2016) Silke Kinzel et al. ACTA NEUROPATHOLOGICA
- Interferon-β therapy specifically reduces pathogenic memory B cells in multiple sclerosis patients by inducing a FAS-mediated apoptosis
- (2016) Fabiana Rizzo et al. IMMUNOLOGY AND CELL BIOLOGY
- Fingolimod therapy modulates circulating B cell composition, increases B regulatory subsets and production of IL-10 and TGFβ in patients with Multiple Sclerosis
- (2016) Shiri Blumenfeld et al. JOURNAL OF AUTOIMMUNITY
- Features of Human CD3+CD20+T Cells
- (2016) Elisabeth Schuh et al. JOURNAL OF IMMUNOLOGY
- Dimethyl Fumarate Treatment Mediates an Anti-Inflammatory Shift in B Cell Subsets of Patients with Multiple Sclerosis
- (2016) Rui Li et al. JOURNAL OF IMMUNOLOGY
- Plasma exchange response in 34 patients with severe optic neuritis
- (2016) Romain Deschamps et al. JOURNAL OF NEUROLOGY
- Increased ex vivo antigen presentation profile of B cells in multiple sclerosis
- (2016) Amandine Mathias et al. Multiple Sclerosis Journal
- Autoantibody-boosted T-cell reactivation in the target organ triggers manifestation of autoimmune CNS disease
- (2016) Anne-Christine Flach et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Increased ex vivo antigen presentation profile of B cells in multiple sclerosis
- (2016) Amandine Mathias et al. Multiple Sclerosis Journal
- The effects of intrathecal rituximab on biomarkers in multiple sclerosis
- (2016) Joanne Topping et al. Multiple Sclerosis and Related Disorders
- Insufficient disease inhibition by intrathecal rituximab in progressive multiple sclerosis
- (2016) Mika Komori et al. Annals of Clinical and Translational Neurology
- Inebilizumab, a B Cell-Depleting Anti-CD19 Antibody for the Treatment of Autoimmune Neurological Diseases: Insights from Preclinical Studies
- (2016) Ding Chen et al. Journal of Clinical Medicine
- B cell-derived transforming growth factor-β1 expression limits the induction phase of autoimmune neuroinflammation
- (2016) Kristbjörg Bjarnadóttir et al. Scientific Reports
- Antibodies produced by clonally expanded plasma cells in multiple sclerosis cerebrospinal fluid cause demyelination of spinal cord explants
- (2015) Kevin Blauth et al. ACTA NEUROPATHOLOGICA
- B-cell very late antigen-4 deficiency reduces leukocyte recruitment and susceptibility to central nervous system autoimmunity
- (2015) Klaus Lehmann-Horn et al. ANNALS OF NEUROLOGY
- IFN-β and multiple sclerosis: Cross-talking of immune cells and integration of immunoregulatory networks
- (2015) Martina Severa et al. CYTOKINE & GROWTH FACTOR REVIEWS
- IFN-β Treatment Requires B Cells for Efficacy in Neuroautoimmunity
- (2015) Ryan D. Schubert et al. JOURNAL OF IMMUNOLOGY
- Structural and functional features of central nervous system lymphatic vessels
- (2015) Antoine Louveau et al. NATURE
- Response to Therapeutic Plasma Exchange as a Rescue Treatment in Clinically Isolated Syndromes and Acute Worsening of Multiple Sclerosis: A Retrospective Analysis of 90 Patients
- (2015) Johannes Ehler et al. PLoS One
- Intrathecal somatic hypermutation of IgM in multiple sclerosis and neuroinflammation
- (2014) Eduardo Beltrán et al. BRAIN
- Comparing comparators: a look at control arms in kidney cancer studies over the years
- (2014) S Bracarda et al. BRITISH JOURNAL OF CANCER
- Rituximab Efficiently Depletes Increased CD20-Expressing T Cells in Multiple Sclerosis Patients
- (2014) Arumugam Palanichamy et al. JOURNAL OF IMMUNOLOGY
- Peripheral B cell depletion and central proinflammatory cytokine reduction following repeated intrathecal administration of rituximab in progressive Multiple Sclerosis
- (2014) Valeria Studer et al. JOURNAL OF NEUROIMMUNOLOGY
- Atacicept in multiple sclerosis (ATAMS): a randomised, placebo-controlled, double-blind, phase 2 trial
- (2014) Ludwig Kappos et al. LANCET NEUROLOGY
- Decreased Dicer expression is linked to increased expression of co-stimulatory molecule CD80 on B cells in multiple sclerosis
- (2014) Latt Latt Aung et al. Multiple Sclerosis Journal
- Natalizumab exerts a suppressive effect on surrogates of B cell function in blood and CSF
- (2014) Clemens Warnke et al. Multiple Sclerosis Journal
- IL-35-producing B cells are critical regulators of immunity during autoimmune and infectious diseases
- (2014) Ping Shen et al. NATURE
- Safety and efficacy of ofatumumab in relapsing-remitting multiple sclerosis: A phase 2 study
- (2014) P. S. Sorensen et al. NEUROLOGY
- A Novel MicroRNA-132-Surtuin-1 Axis Underlies Aberrant B-cell Cytokine Regulation in Patients with Relapsing-Remitting Multiple Sclerosis
- (2014) Yusei Miyazaki et al. PLoS One
- Immunoglobulin class-switched B cells form an active immune axis between CNS and periphery in multiple sclerosis
- (2014) A. Palanichamy et al. Science Translational Medicine
- B cells populating the multiple sclerosis brain mature in the draining cervical lymph nodes
- (2014) J. N. H. Stern et al. Science Translational Medicine
- Therapeutic Plasma Exchange in Glucocorticosteroid-Unresponsive Patients With Clinically Isolated Syndrome
- (2014) Johannes Ehler et al. THERAPEUTIC APHERESIS AND DIALYSIS
- The Effect of Glatiramer Acetate Therapy on Functional Properties of B Cells From Patients With Relapsing-Remitting Multiple Sclerosis
- (2014) Sara J. Ireland et al. JAMA Neurology
- CD20+inflammatory T-cells are present in blood and brain of multiple sclerosis patients and can be selectively targeted for apoptotic elimination
- (2014) Janet E. Holley et al. Multiple Sclerosis and Related Disorders
- Intrathecal anti-CD20 efficiently depletes meningeal B cells in CNS autoimmunity
- (2014) Klaus Lehmann-Horn et al. Annals of Clinical and Translational Neurology
- Glatiramer acetate attenuates the pro-migratory profile of adhesion molecules on various immune cell subsets in multiple sclerosis
- (2013) J. Sellner et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- MHC class II–dependent B cell APC function is required for induction of CNS autoimmunity independent of myelin-specific antibodies
- (2013) Nicolas Molnarfi et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Increased B Cell and Cytotoxic NK Cell Proportions and Increased T Cell Responsiveness in Blood of Natalizumab-Treated Multiple Sclerosis Patients
- (2013) Johan Mellergård et al. PLoS One
- Targeting B cells in the treatment of multiple sclerosis: recent advances and remaining challenges
- (2013) Klaus Lehmann-Horn et al. Therapeutic Advances in Neurological Disorders
- Antibody-independent B cell effector functions in relapsing remitting Multiple Sclerosis: Clues to increased inflammatory and reduced regulatory B cell capacity
- (2012) Sara J. Ireland et al. AUTOIMMUNITY
- Functional identification of pathogenic autoantibody responses in patients with multiple sclerosis
- (2012) Christina Elliott et al. BRAIN
- Current Treatment Strategies for Multiple Sclerosis - Efficacy Versus Neurological Adverse Effects
- (2012) Martin S. Weber et al. CURRENT PHARMACEUTICAL DESIGN
- B cell depletion therapy ameliorates autoimmune disease through ablation of IL-6–producing B cells
- (2012) Tom A. Barr et al. JOURNAL OF EXPERIMENTAL MEDICINE
- CXCL13 is the major determinant for B cell recruitment to the CSF during neuroinflammation
- (2012) Markus C Kowarik et al. Journal of Neuroinflammation
- Alemtuzumab versus interferon beta 1a as first-line treatment for patients with relapsing-remitting multiple sclerosis: a randomised controlled phase 3 trial
- (2012) Jeffrey A Cohen et al. LANCET
- Alemtuzumab for patients with relapsing multiple sclerosis after disease-modifying therapy: a randomised controlled phase 3 trial
- (2012) Alasdair J Coles et al. LANCET
- Progressive multiple sclerosis: pathology and pathogenesis
- (2012) Hans Lassmann et al. Nature Reviews Neurology
- Related B cell clones populate the meninges and parenchyma of patients with multiple sclerosis
- (2011) Laura Lovato et al. BRAIN
- Meningeal inflammation is widespread and linked to cortical pathology in multiple sclerosis
- (2011) Owain W. Howell et al. BRAIN
- Glatiramer Acetate in the Treatment of Multiple Sclerosis
- (2011) Patrice H. Lalive et al. CNS DRUGS
- Natalizumab treatment perturbs memory- and marginal zone-like B-cell homing in secondary lymphoid organs in multiple sclerosis
- (2011) Raquel Planas et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Lipid arrays identify myelin-derived lipids and lipid complexes as prominent targets for oligoclonal band antibodies in multiple sclerosis
- (2011) Kathryn M. Brennan et al. JOURNAL OF NEUROIMMUNOLOGY
- Antibody response in MOG35–55 induced EAE
- (2011) Patrice H. Lalive et al. JOURNAL OF NEUROIMMUNOLOGY
- Anti-CD20 B-cell depletion enhances monocyte reactivity in neuroimmunological disorders
- (2011) Klaus Lehmann-Horn et al. Journal of Neuroinflammation
- Ocrelizumab in relapsing-remitting multiple sclerosis: a phase 2, randomised, placebo-controlled, multicentre trial
- (2011) Ludwig Kappos et al. LANCET
- Favourable response to plasma exchange in tumefactive CNS demyelination with delayed B-cell response
- (2011) Christian L Seifert et al. Multiple Sclerosis Journal
- Disappearance of cerebrospinal fluid oligoclonal bands after natalizumab treatment of multiple sclerosis patients
- (2011) Felipe von Glehn et al. Multiple Sclerosis Journal
- Intrathecal effects of daclizumab treatment of multiple sclerosis
- (2011) B. Bielekova et al. NEUROLOGY
- Differential effects of fingolimod (FTY720) on immune cells in the CSF and blood of patients with MS
- (2011) M. C. Kowarik et al. NEUROLOGY
- Interaction of Epstein-Barr virus (EBV) with human B-lymphocytes
- (2010) George Klein et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- The role of antibodies in multiple sclerosis
- (2010) Martin S. Weber et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- Characterization of a rare IL-10-competent B-cell subset in humans that parallels mouse regulatory B10 cells
- (2010) Y. Iwata et al. BLOOD
- Memory B cells from a subset of treatment-naïve relapsing-remitting multiple sclerosis patients elicit CD4+ T-cell proliferation and IFN-γ production in response to myelin basic protein and myelin oligodendrocyte glycoprotein
- (2010) Christopher T. Harp et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Increased expression of B cell-associated regulatory cytokines by glatiramer acetate in mice with experimental autoimmune encephalomyelitis
- (2010) Sakhina Begum-Haque et al. JOURNAL OF NEUROIMMUNOLOGY
- Augmentation of regulatory B cell activity in experimental allergic encephalomyelitis by glatiramer acetate
- (2010) Sakhina Begum-Haque et al. JOURNAL OF NEUROIMMUNOLOGY
- B-Cell Depletion In Vitro and In Vivo with an Afucosylated Anti-CD19 Antibody
- (2010) R. Herbst et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Multiple sclerosis: risk factors, prodromes, and potential causal pathways
- (2010) Sreeram V Ramagopalan et al. LANCET NEUROLOGY
- Absence of Epstein-Barr virus in the brain and CSF of patients with multiple sclerosis
- (2010) S. A. Sargsyan et al. NEUROLOGY
- Rituximab in patients with primary progressive multiple sclerosis: Results of a randomized double-blind placebo-controlled multicenter trial
- (2009) Kathleen Hawker et al. ANNALS OF NEUROLOGY
- Depletion of B Lymphocytes From Cerebral Perivascular Spaces by Rituximab
- (2009) Maria del Pilar Martin et al. ARCHIVES OF NEUROLOGY
- Epstein–Barr virus infection is not a characteristic feature of multiple sclerosis brain
- (2009) Simon N. Willis et al. BRAIN
- Spontaneous relapsing-remitting EAE in the SJL/J mouse: MOG-reactive transgenic T cells recruit endogenous MOG-specific B cells
- (2009) Bernadette Pöllinger et al. JOURNAL OF EXPERIMENTAL MEDICINE
- The prognostic significance of cerebrospinal fluid in multiple sclerosis
- (2009) Sasitorn Siritho et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- Memory and naïve B-cell subsets in patients with multiple sclerosis
- (2009) Masaaki Niino et al. NEUROSCIENCE LETTERS
- Contactin-2/TAG-1-directed autoimmunity is identified in multiple sclerosis patients and mediates gray matter pathology in animals
- (2009) T. Derfuss et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- B Cell Survival in Intragraft Tertiary Lymphoid Organs After Rituximab Therapy
- (2009) Olivier Thaunat et al. TRANSPLANTATION
- Matching of oligoclonal immunoglobulin transcriptomes and proteomes of cerebrospinal fluid in multiple sclerosis
- (2008) Birgit Obermeier et al. NATURE MEDICINE
- Natalizumab disproportionately increases circulating pre-B and B cells in multiple sclerosis
- (2008) M. Krumbholz et al. NEUROLOGY
- B-Cell Depletion with Rituximab in Relapsing–Remitting Multiple Sclerosis
- (2008) Stephen L. Hauser et al. NEW ENGLAND JOURNAL OF MEDICINE
- IL-6 controls Th17 immunity in vivo by inhibiting the conversion of conventional T cells into Foxp3+ regulatory T cells
- (2008) T. Korn et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search